Chevy Chase-based New Enterprise Associates has joined in a $10 million financing for Cydan LLC, a Cambridge, Mass.-based orphan drug accelerator.
The additional funding comes months after the project’s launch in April, and brings its total financing to $26 million. Lundbeckfond Ventures and Bay City Capital led the most recent financing.
{iframe}http://www.bizjournals.com/washington/blog/techflash/2013/10/new-enterprise-associates-joins-10m.html{/iframe}